Spotlight

NGDI Welcomes new Member Indel Therapeutics Inc.

NGDI Welcomes new Member Indel Therapeutics Inc.

Indel Therapeutics Inc. is a biopharmaceutical company dedicated to developing new drugs to address the global health crisis.

CORE Partners with NGDI-UBC in Neglected Global Disease Research

CORE Partners with NGDI-UBC in Neglected Global Disease Research

Projects will support CORE trainees and NGDI members.

Tier One Canada Research Chair in Global Health